3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Hepatocellular
6
Urinary Bladder Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Unresectable Hepatocellular Carcinoma
1
Triple Negative Breast Neoplasms
1
Small Cell Lung Carcinoma
1
Liver Neoplasms
1
Hypertension, Portal
1
Fibrosis
1
Fallopian Tube Neoplasms
1
Endometrial Neoplasms
1
Diabetes Mellitus, Insulin-Dependent, 12
1
Colorectal Neoplasms
1
Cholangiocarcinoma
1
Carcinoma
1
Biliary Tract Neoplasms
1
Interventions
ribociclib
2
Specimen Handling
2
tucatinib
1
trastuzumab biosimilar HLX02
1
pertuzumab
1
pembrolizumab
1
exemestane
1
durvalumab
1
Watchful Waiting
1
Trastuzumab
1
Taxes
1
Paclitaxel
1
PF-05280014
1
Ontruzant
1
Ogivri
1
Observation
1
Magnetic Resonance Spectroscopy
1
Letrozole
1
Immunoglobulin G
1
Genetic Testing
1
Fulvestrant
1
Drug Therapy
1
Doxorubicin
1
Docetaxel
1
Disulfides
1
Cyclophosphamide
1
Carboplatin
1
Biopsy
1
Anastrozole
1
2C4 antibody
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Anatomic Stage II Breast Cancer AJCC v8
×
tremelimumab
×
30 days
×
Clear all
No trials found.